Bionano Genomics Announces 2023 Symposium Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Applications

SAN DIEGO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced its 2023 Symposium, which is the quintessential event for the optical genome mapping (OGM) community to present its progress to the world. It will feature four consecutive days of OGM presentations delivered by 25 different customers worldwide across a wide range of genetic diseases, cancer and cell bioprocessing applications. The Symposium will take place virtually from January 23 to 26, 2023. During these four days, customers will showcase their latest research findings using OGM in constitutional, hematologic malignancies, and solid tumor applications. Each day will feature oral customer presentations, a live panel with Q&A and a wide range of scientific posters within the virtual exhibition hall.

“At Bionano, we are working to transform the way the world sees the genome,” said Erik Holmlin, PhD, president and chief executive officer of Bionano. “Symposium is our platform for the community of OGM users to describe its utility and how it can be integrated with other genome analysis tools to reveal more answers for genetic disease and cancer research applications. What impresses me most about the lineup for 2023 is the sheer breadth of topics, ranging from neural tube defects in prenatal testing to homologous recombination deficiency (HRD) analysis in breast cancer and drug development with cell bioprocessing QC.”  

“We were thrilled with the engagement of the OGM community at 2022 Symposium which represented 82 different countries. We believe our customers around the world have made tremendous progress with the implementation of OGM in their laboratories since last year. The lineup of researchers for our 2023 Symposium is our most exciting to date, with over 25 global experts detailing their use of OGM to drive discoveries across a number of clinical research applications,” said Alka Chaubey, chief medical officer at Bionano.

Each session of Symposium will start at 7:00 am PST and will last approximately 3 hours. After the scientific presentations, the speakers will join for a live panel discussion and Q&A moderated by Dr. Chaubey. In addition, each day will feature a scientific poster exhibit. Below is an overview of the presentation topics for each day of the event.

Monday, January 23: Oncology- Heme malignancies
Global researchers studying genomic variants involved in hematologic malignancies will share results from studies using OGM for research in Myelodysplastic syndromes (MDS), Chronic lymphocytic leukemias (CLL), lymphoma and Acute Myeloid Leukemia (AML). Speakers will highlight the use of new tools to find more pathogenic chromosomal aberrations while also simplifying laboratory workflows.